Pyroptosis in glioma: Current management and future application

Area of Science:

• Neuro-oncology
• Cellular Biology
• Immunology

Background:

• Glioma is a primary brain tumor with poor prognosis, challenging current treatments like immunotherapy due to the blood-brain barrier and immunosuppressive tumor microenvironment.
• Pyroptosis, a lytic programmed cell death, is implicated in glioma development and progression.
• While pyroptosis offers therapeutic potential, excessive cell death can cause inflammation and potentially hinder treatment outcomes.

Purpose of the Study:

• To explore the molecular mechanisms of pyroptosis.
• To discuss the induction of pyroptosis in glioma therapy.
• To review current glioma treatments and pyroptosis's role.

Main Methods:

• Literature review of pyroptosis pathways and their role in glioma.
• Analysis of pyroptosis induction strategies for cancer therapy.
• Synthesis of information on current glioma treatments and pyroptosis applications.

Main Results:

• Pyroptosis pathways are complex and influence glioma occurrence, progression, and metastasis.
• Pyroptosis can be induced for cancer therapy, but careful control is needed to avoid adverse effects.
• Integrating pyroptosis into existing glioma treatment strategies may offer new therapeutic avenues.

Conclusions:

• Pyroptosis presents a promising avenue for glioma treatment, offering a way to bypass conventional therapy limitations.
• Further research into pyroptosis mechanisms and controlled induction is essential for effective clinical application in glioma.
• This review provides insights into leveraging pyroptosis for improved glioma management.